MiR-199a-3p enhances breast cancer cell sensitivity to cisplatin by downregulating TFAM (TFAM)
Xuelong Fan et al, 2017, Biomedicine & Pharmacotherapy CrossRef
Zinc finger protein 468 up-regulation of TFAM contributes to the malignant growth and cisplatin resistance of breast cancer cells
Zhaoyang Jia et al, 2024, Cell Division CrossRef
Effects of the anti-inflammatory drug celecoxib on cell death signaling in human colon cancer
Ryuto Maruyama et al, 2023, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
Estrogen- and estrogen receptor (ER)-mediated cisplatin chemoresistance in cancer
Caglar Berkel et al, 2021, Life Sciences CrossRef
High leukocyte mitochondrial DNA copy number contributes to poor prognosis in breast cancer patients
Wenzhe Zhang et al, 2023, BMC Cancer CrossRef
Mitochondria-Related TFAM and POLG Gene Variants and Associations with Tumor Characteristics and Patient Survival in Head and Neck Cancer
Ieva Golubickaite et al, 2023, Genes CrossRef
Mitochondrial HMG-Box Containing Proteins: From Biochemical Properties to the Roles in Human Diseases
Veronika Vozáriková et al, 2020, Biomolecules CrossRef
Expression Profile of mRNAs and miRNAs Related to the Oxidative-Stress Phenomenon in the Ishikawa Cell Line Treated Either Cisplatin or Salinomycin
Szymon Januszyk et al, 2022, Biomedicines CrossRef
PGC1α promotes cisplatin resistance in human ovarian carcinoma cells through upregulation of mitochondrial biogenesis
Luyan Shen et al, 2018, International Journal of Oncology CrossRef
Mitochondria‑related TFAM gene variants and their effects on patients with cervical cancer
Ieva Golubickaite et al, 2021, Biomedical Reports CrossRef
Mitochondria Transcription Factor A: A Putative Target for the Effect of Melatonin on U87MG Malignant Glioma Cell Line
Daiane Franco et al, 2018, Molecules CrossRef
Mitochondrial Metabolic Programming and Crosstalk to Nucleus
Mariana Abrantes do Amaral et al, 2023, Current Tissue Microenvironment Reports CrossRef